SEC 13F Intelligence

Managers / Q1 2020 · view latest →

Slate Path Capital LP

CIK 0001559706 · 717 5TH AVENUE, 16TH FL., NEW YORK, NY, 10022 · 212-257-4330

Reported Value
$1.3B
Q1 2020
Positions
26
Filings on Record
30
2019–present window
Filed
May 15, 2020
original filing

Summary

Slate Path Capital LP reported $1.3B in U.S.-listed holdings across 26 positions for Q1 2020.

Its largest position, ABX, represents 14.3% of the portfolio.

Compared with Q4 2019, the fund opened 7 new positions and exited 7.

Portfolio Metrics

Turnover
+12.8%
vs prior filed quarter
Top-10 Concentration
+85.4%
share of reported value
Largest Position
+14.3%
Barrick Gold Corporation
New / Exited
7 / 7
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $887MQ4 ’18Q1 ’19: $1.2BQ2 ’19: $2.2BQ3 ’19: $1.5BQ4 ’19: $1.9BQ4 ’19Q1 ’20: $1.3BQ2 ’20: $1.7BQ3 ’20: $1.8BQ4 ’20: $1.8BQ4 ’20Q1 ’21: $1.5BQ2 ’21: $1.8BQ3 ’21: $2.2BQ4 ’21: $1.9BQ4 ’21Q1 ’22: $2.0BQ2 ’22: $1.6BQ3 ’22: $1.5BQ4 ’22: $1.9BQ4 ’22Q1 ’23: $2.1BQ2 ’23: $2.7BQ3 ’23: $3.6BQ4 ’23: $4.5BQ4 ’23Q1 ’24: $5.0BQ2 ’24: $5.3BQ3 ’24: $6.5BQ4 ’24: $5.5BQ4 ’24Q1 ’25: $5.5BQ2 ’25: $5.8BQ3 ’25: $6.5BQ4 ’25: $7.4BQ4 ’25Q1 ’26: $6.7Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 84.6%Other: 14.2%ETP: 0.9%ADR: 0.3%
  • Common Stock · 84.6% · $1.1B
  • Other · 14.2% · $186M
  • ETP · 0.9% · $11M
  • ADR · 0.3% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MYLAN NVNEW+10.79M10.79M+$161M$161M
IRWDIRONWOOD PHARMACEUTICALS INCNEW+1.34M1.34M+$14M$14M
WWAYFAIR INCNEW+70.0K70.0K+$4M$4M
ATRAGBXATARA BIOTHERAPEUTICS INCNEW+420.0K420.0K+$4M$4M
CYCNUSDCYCLERION THERAPEUTICS INCNEW+1.20M1.20M+$3M$3M
TRANSOCEAN LTDNEW+470.0K470.0K+$545,000$545,000
ARCH1USDARCH COAL INCNEW+18.0K18.0K+$520,000$520,000
ENDO INTL PLCADDED+3.03M3.38M+$11M$13M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

24 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ABXBARRICK GOLD CORPORATIONhistory →COM14.25%$186M10.14M
2CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A12.58%$164M376.0K
3MYLAN NVSHS EURO12.33%$161M10.79M
4NYTNEW YORK TIMES COhistory →CL A10.20%$133M4.33M
5SNAPSNAP INChistory →CL A8.74%$114M9.59M
6ZZILLOW GROUP INChistory →CL C CAP STK · CL A6.42%$84M2.33M
7ALNYALNYLAM PHARMACEUTICALS INChistory →COM5.99%$78M718.0K
8MOSMOSAIC CO NEWhistory →COM5.43%$71M6.54M
9BHCBAUSCH HEALTH COS INChistory →COM5.05%$66M4.25M
10PAASPAN AMERN SILVER CORPhistory →COM4.87%$63M4.43M
11KEXKIRBY CORPhistory →COM4.32%$56M1.30M
12FCXFREEPORT-MCMORAN INChistory →CL B3.90%$51M7.53M
13IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A1.04%$14M1.34M
14ENDO INTL PLCSHS0.96%$13M3.38M
15CUE1EURCUE BIOPHARMA INChistory →COM0.95%$12M870.7K
16UNIQURE NVSHS0.51%$7M140.0K
17LXLEXINFINTECH HLDGS LTDADR0.30%$4M440.0K
18WWAYFAIR INCCL A0.29%$4M70.0K
19BLUE APRON HLDGS INCCL A NEW0.27%$4M297.0K
20ATRAGBXATARA BIOTHERAPEUTICS INCCOM0.27%$4M420.0K
21CYCNUSDCYCLERION THERAPEUTICS INCCOM0.24%$3M1.20M
22INTELSAT S ACOM0.13%$2M1.10M
23TRANSOCEAN LTDREG SHS0.04%$545,000470.0K
24ARCH1USDARCH COAL INCCL A0.04%$520,00018.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$6.7B44May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$7.4B51Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.5B51Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$5.8B43Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$5.5B50May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$5.5B51Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$6.5B68Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$5.3B62Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$5.0B62May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$4.5B59Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$3.6B50Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.7B49Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.1B43May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.9B43Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.5B50Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.6B48Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.0B43May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.9B40Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.2B40Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.8B37Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.5B36May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.8B30Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.8B26Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.7B33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.3B26May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.9B27Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.5B29Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$2.2B30Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.2B21May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$887M22Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.